Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
Open accessThe DOI matches its Crossref record; 306 of the 306 references it cites were found in a registry or an index.
Abstract
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of liver dysfunction in the Western world and is increasing owing to its close association with obesity and insulin resistance. NAFLD represents a spectrum of liver disease that, in a minority of patients, can lead to progressive nonalcoholic steatohepatitis (NASH), fibrosis, and ultimately hepatocellular carcinoma and liver failure. NAFLD is a complex trait resulting from the interaction between environmental exposure and a susceptible polygenic background and comprising multiple independent modifiers of risk, such as the microbiome. The molecular mechanisms that combine to define the transition to NASH and progressive disease are complex, and consequently, no pharmacological therapy currently exists to treat NASH. A better understanding of the pathogenesis of NAFLD is critical if new treatments are to be discovered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–306 of 306
Armstrong, M. J., Houlihan, D. D., Bentham, L., Shaw, J. C., Cramb, R., Olliff, S., Gill, P. S., Neuberger, J. M., Lilford, R. J., & Newsome, P. N. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.03.020 · Cited by 300
Diagnosis of Nonalcoholic Fatty Liver Disease: Invasive versus Noninvasive
Wieckowska, A., & Feldstein, A. (2008) · Seminars in Liver Disease · doi:10.1055/s-0028-1091983 · Cited by 300
Characterization of the human patatin-like phospholipase family
Wilson, P. A., Gardner, S. D., Lambie, N. M., Commans, S. A., & Crowther, D. J. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600185-jlr200 · Cited by 297
Expression, regulation, and triglyceride hydrolase activity of Adiponutrin family members
Lake, A. C., Sun, Y., Li, J.-L., Kim, J. E., Johnson, J. W., Li, D., Revett, T., Shih, H. H., Liu, W., Paulsen, J. E., et al. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500290-jlr200 · Cited by 295
Zhang, S., Wang, J., Liu, Q., & Harnish, D. C. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.025 · Cited by 290
Kotronen, A., Johansson, L. E., Johansson, L. M., Roos, C., Westerbacka, J., Hamsten, A., Bergholm, R., Arkkila, P., Arola, J., Kiviluoto, T., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1285-z · Cited by 290
The lysosomal-mitochondrial axis in free fatty acid–induced hepatic lipotoxicity
Li, Z., Berk, M., McIntyre, T. M., Gores, G. J., & Feldstein, A. E. (2008) · Hepatology · doi:10.1002/hep.22183 · Cited by 289
Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome
Abid, A., Taha, O., Nseir, W., Farah, R., Grosovski, M., & Assy, N. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.05.033 · Cited by 287
Weyemi, U., Lagente-Chevallier, O., Boufraqech, M., Prenois, F., Courtin, F., Caillou, B., Talbot, M., Dardalhon, M., Al Ghuzlan, A., Bidart, J.-M., et al. (2012) · Oncogene · doi:10.1038/onc.2011.327 · Cited by 285
Rydel, T. J., Williams, J. M., Krieger, E., Moshiri, F., Stallings, W. C., Brown, S. M., Pershing, J. C., Purcell, J. P., & Alibhai, M. F. (2003) · Biochemistry · doi:10.1021/bi027156r · Cited by 284
Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis
Li, J. Z., Huang, Y., Karaman, R., Ivanova, P. T., Brown, H. A., Roddy, T., Castro-Perez, J., Cohen, J. C., & Hobbs, H. H. (2012) · Journal of Clinical Investigation · doi:10.1172/jci65179 · Cited by 283
Miura, K., Yang, L., van Rooijen, N., Brenner, D. A., Ohnishi, H., & Seki, E. (2013) · Hepatology · doi:10.1002/hep.26081 · Cited by 282
Multigenerational epigenetic adaptation of the hepatic wound-healing response
Zeybel, M., Hardy, T., Wong, Y. K., Mathers, J. C., Fox, C. R., Gackowska, A., Oakley, F., Burt, A. D., Wilson, C. L., Anstee, Q. M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2893 · Cited by 279 · cited 1×
“A recent translational study in a small cohort of NAFLD patients demonstrated that greater DNA methylation at the PPARγ promoter associated with advanced (F3–4) disease, suggesting that this epigenetic signature may favor stellate cell activation and subsequent hepatic fibrogenesis (274).”
Self-citationDysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice
De Minicis, S., Rychlicki, C., Agostinelli, L., Saccomanno, S., Candelaresi, C., Trozzi, L., Mingarelli, E., Facinelli, B., Magi, G., Palmieri, C., et al. (2014) · Hepatology · doi:10.1002/hep.26695 · Cited by 279 · cited 2×
“This microbiome was characterized by an increased amount of gram-negative proteobacteria, with a virtual disappearance of bifidobacteria, and caused more severe liver fibrosis in control mice when subjected to BDL, their having received the gut microbiota from high-fat-diet fed mice prior to injury (304).”
BackgroundA Novel Role for the Dioxin Receptor in Fatty Acid Metabolism and Hepatic Steatosis
Lee, J. H., Wada, T., Febbraio, M., He, J., Matsubara, T., Lee, M. J., Gonzalez, F. J., & Xie, W. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.033 · Cited by 276
Baeck, C., Wei, X., Bartneck, M., Fech, V., Heymann, F., Gassler, N., Hittatiya, K., Eulberg, D., Luedde, T., Trautwein, C., et al. (2014) · Hepatology · doi:10.1002/hep.26783 · Cited by 270 · cited 1×
“Indeed, CCR2 or CCL2 inhibitors prevent the progression of NASH and fibrosis (229, 230) and also enhance the clearance of scar tissue in the fibrosis resolution phase (231).”
BackgroundGuerra Ruiz, A., Casafont, F., Crespo, J., Cayón, A., Mayorga, M., Estebanez, A., Fernadez-Escalante, J. C., & Pons-Romero, F. (2007) · Obesity Surgery · doi:10.1007/s11695-007-9243-7 · Cited by 269
Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression
Claudel, T., Inoue, Y., Barbier, O., Duran-Sandoval, D., Kosykh, V., Fruchart, J., Fruchart, J.-C., Gonzalez, F. J., & Staels, B. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00896-5 · Cited by 268
KIRSCH, R., CLARKSON, V., SHEPHARD, E. G., MARAIS, D. A., JAFFER, M. A., WOODBURNE, V. E., KIRSCH, R. E., & HALL, P. D. L. M. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.03198.x · Cited by 262
Syn, W., Jung, Y., Omenetti, A., Abdelmalek, M., Guy, C. D., Yang, L., Wang, J., Witek, R. P., Fearing, C. M., Pereira, T. A., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.051 · Cited by 258
Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis #
Witek, R. P., Stone, C. W., Karaca, G. F., Syn, W.-K., Pereira, T. A., Agboola, K. M., Omenetti, A., Jung, Y., Teaberry, V., Choi, S. S., et al. (2009) · Hepatology · doi:10.1002/hep.23167 · Cited by 253
Chen, W., Chang, B., Li, L., & Chan, L. (2010) · Hepatology · doi:10.1002/hep.23812 · Cited by 247
George, J., Pera, N., Phung, N., Leclercq, I., Yun Hou, J., & Farrell, G. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00376-3 · Cited by 247
Basantani, M. K., Sitnick, M. T., Cai, L., Brenner, D. S., Gardner, N. P., Li, J. Z., Schoiswohl, G., Yang, K., Kumari, M., Gross, R. W., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m011205 · Cited by 242
Teratani, T., Tomita, K., Suzuki, T., Oshikawa, T., Yokoyama, H., Shimamura, K., Tominaga, S., Hiroi, S., Irie, R., Okada, Y., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.09.049 · Cited by 241 · cited 1×
“Given recent evidence suggesting that cholesterol accumulation in HSCs promotes NAFLD fibrosis (214, 271), an appealing hypothesis is that TM6SF2 may act as a master regulator of metabolic syndrome outcome, with the”
BackgroundBallooned hepatocytes in steatohepatitis: The value of keratin immunohistochemistry for diagnosis
Lackner, C., Gogg-Kamerer, M., Zatloukal, K., Stumptner, C., Brunt, E. M., & Denk, H. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.026 · Cited by 241
Andreelli, F., Foretz, M., Knauf, C., Cani, P. D., Perrin, C., Iglesias, M. A., Pillot, B., Bado, A., Tronche, F., Mithieux, G., et al. (2006) · Endocrinology · doi:10.1210/en.2005-0898 · Cited by 237
III. Peroxisomal β-oxidation, PPARα, and steatohepatitis
Reddy, J. K. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.281.6.g1333 · Cited by 236
Short‐chain fatty acid topical treatment in distal ulcerative colitis
VERNIA, P., MARCHEGGIANO, A., CAPRILLI, R., FRIERI, G., CORRAO, G., VALPIANI, D., PAOLO, M. C. D., PAOLUZI, P., & TORSOLI, A. (1995) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1995.tb00386.x · Cited by 233
Drenick, E. J., Fisler, J., & Johnson, D. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80403-4 · Cited by 226
The Roles of Leptin and Adiponectin
Ding, X., Saxena, N. K., Lin, S., Xu, A., Srinivasan, S., & Anania, F. A. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62476-5 · Cited by 225
Ethnicity and nonalcoholic fatty liver disease
Bambha, K., Belt, P., Abraham, M., Wilson, L. A., Pabst, M., Ferrell, L., Unalp-Arida, A., & Bass, N. (2012) · Hepatology · doi:10.1002/hep.24726 · Cited by 222
Choi, S. S., Omenetti, A., Witek, R. P., Moylan, C. A., Syn, W.-K., Jung, Y., Yang, L., Sudan, D. L., Sicklick, J. K., Michelotti, G. A., et al. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00292.2009 · Cited by 219 · cited 1×
“Hedgehog pathway signaling modulates myofibroblast transdifferentiation within the space of Disse; hedgehog pathway–stimulated immature ductular cells secrete chemokines resulting in accumulation of natural killer T (NKT) cells in the liver (225).”
BackgroundSookoian, S., Castaño, G. O., Scian, R., Mallardi, P., Fernández Gianotti, T., Burgueño, A. L., San Martino, J., & Pirola, C. J. (2015) · Hepatology · doi:10.1002/hep.27556 · Cited by 219
Autophagy in nonalcoholic steatohepatitis
Amir, M., & Czaja, M. J. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.4 · Cited by 216
Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity
Malhi, H., Barreyro, F. J., Isomoto, H., Bronk, S. F., & Gores, G. J. (2007) · Gut · doi:10.1136/gut.2006.118059 · Cited by 214
Kupffer cells mediate leptin-induced liver fibrosis
Wang, J., Leclercq, I., Brymora, J. M., Xu, N., Ramezani–Moghadam, M., London, R. M., Brigstock, D., & George, J. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.011 · Cited by 210 · cited 1×
“Leptin also targets Kupffer cells and sinusoidal endothelial cells, increasing transforming growth factor β (TGFβ) expression (200).”
BackgroundHereditary Diabetes in Genetically Obese Mice
Mayer, J., Bates, M. W., & Dickie, M. M. (1951) · Science · doi:10.1126/science.113.2948.746 · Cited by 209
Romeo, S., Sentinelli, F., Dash, S., Yeo, G. S. H., Savage, D. B., Leonetti, F., Capoccia, D., Incani, M., Maglio, C., Iacovino, M., et al. (2010) · International Journal of Obesity · doi:10.1038/ijo.2009.216 · Cited by 208
Baumeister, S. E., Völzke, H., Marschall, P., John, U., Schmidt, C., Flessa, S., & Alte, D. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.10.024 · Cited by 208
TNFα release by the nonfat cells of human adipose tissue
Fain, J. N., Bahouth, S. W., & Madan, A. K. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802594 · Cited by 203
How big a problem is non-alcoholic fatty liver disease?
Anstee, Q. M., McPherson, S., & Day, C. P. (2011) · BMJ · doi:10.1136/bmj.d3897 · Cited by 200
Self-citationSato, R., Miyamoto, W., Inoue, J., Terada, T., Imanaka, T., & Maeda, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.24714 · Cited by 193
Final results of a long-term, clinical follow-up in fatty liver patients
Dam-Larsen, S., Becker, U., Franzmann, M.-B., Larsen, K., Christoffersen, P., & Bendtsen, F. (2009) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520903171284 · Cited by 187
Zeybel, M., Hardy, T., Robinson, S. M., Fox, C., Anstee, Q. M., Ness, T., Masson, S., Mathers, J. C., French, J., White, S., et al. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0056-6 · Cited by 180 · cited 1×
“Another recently reported study showed that key antifibrogenic genes were hypomethylated in mild NAFLD, whereas profibrogenic genes were hypomethylated in severe NAFLD (276).”
BackgroundSelf-citationNonalcoholic steatohepatitis: a search for factual animal models
Sanches, S. C. L., Ramalho, L. N. Z., Augusto, M. J., da Silva, D. M., & Ramalho, F. S. (2015) · BioMed Research International · doi:10.1155/2015/574832 · Cited by 174 · cited 1×
“Vital insights into the pathogenesis and underlying mechanisms of NAFLD have been gained from the study of existing animal models; detailed discussion is outside the scope of this article and is reviewed elsewhere (87) and summarized in Table 1.”
BackgroundBax inhibition protects against free fatty acid-induced lysosomal permeabilization
Feldstein, A. E., Werneburg, N. W., Li, Z., Bronk, S. F., & Gores, G. J. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00509.2005 · Cited by 174 · cited 1×
“Redistribution of Cathepsin B into the cytoplasm is present in livers of patients with NAFLD (183).”
BackgroundMansbach, C. M., & Gorelick, F. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00299.2007 · Cited by 170
Doege, H., Grimm, D., Falcon, A., Tsang, B., Storm, T. A., Xu, H., Ortegon, A. M., Kazantzis, M., Kay, M. A., & Stahl, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803510200 · Cited by 169
Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma
Chambers, J. C., Zhang, W., Sehmi, J., Li, X., Wass, M. N., van der Harst, P., Hólm, H., Sanna, S., Kavousi, M., Baumeister, S. E., et al. (2011) · Archive ouverte UNIGE (University of Geneva) · doi:10.5451/unibas-ep81762 · Cited by 169
Ratziu, V., Sheikh, M. Y., Sanyal, A. J., Lim, J. K., Conjeevaram, H., Chalasani, N., Abdelmalek, M., Bakken, A., Renou, C., Palmer, M., et al. (2012) · Hepatology · doi:10.1002/hep.24747 · Cited by 164
Cellular senescence, ageing and disease
Burton, D. G. A. (2008) · AGE · doi:10.1007/s11357-008-9075-y · Cited by 161
Dries, D. R., Gallegos, L. L., & Newton, A. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.c600268200 · Cited by 159
Anstee, Q. M., Concas, D., Kudo, H., Levene, A., Pollard, J., Charlton, P., Thomas, H. C., Thursz, M. R., & Goldin, R. D. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.016 · Cited by 158
Self-citationRisk Factors for Hepatocellular Carcinoma in Patients With Alcoholic or Viral C Cirrhosis
N’Kontchou, G., Paries, J., Htar, M. T. T., Ganne–Carrie, N., Costentin, L., Grando–Lemaire, V., Trinchet, J., & Beaugrand, M. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.05.013 · Cited by 158
Makkonen, J., Pietiläinen, K. H., Rissanen, A., Kaprio, J. A., & Yki‐Järvinen, H. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.025 · Cited by 156
Mann, D. A. (2014) · Hepatology · doi:10.1002/hep.27131 · Cited by 153 · cited 1×
“The three most commonly described constituent mechanisms are DNA (CpG) methylation, posttranslational histone modifications, and microRNAs (miRNAs); these mechanisms and their relevance to liver disease have been reviewed recently (272).”
BackgroundCaron, S., Huaman Samanez, C., Dehondt, H., Ploton, M., Briand, O., Lien, F., Dorchies, E., Dumont, J., Postic, C., Cariou, B., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01004-12 · Cited by 150
Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis?
Chalasani, N. (2003) · The American Journal of Gastroenterology · doi:10.1016/j.amjgastroenterol.2003.09.037 · Cited by 148
Palmer, N. D., Musani, S. K., Yerges-Armstrong, L. M., Feitosa, M. F., Bielak, L. F., Hernaez, R., Kahali, B., Carr, J. J., Harris, T. B., Jhun, M. A., et al. (2013) · Hepatology · doi:10.1002/hep.26440 · Cited by 147
Dual Roles of Adiponectin / Acrp30 In Vivo as an Anti-Diabetic and Anti- Atherogenic Adipokine
Yamauchi, T., Hara, K., Kubota, N., Terauchi, Y., Tobe, K., Froguel, P., Nagai, R., & Kadowaki, T. (2003) · Current Drug Targets - Immune, Endocrine & Metabolic Disorders · doi:10.2174/1568008033340090 · Cited by 142
The epidemiology of fatty liver
Bellentani, S., Bedogni, G., Miglioli, L., & Tiribelli, C. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200411000-00002 · Cited by 142
Gao, D., Wei, C., Chen, L., Huang, J., Yang, S., & Diehl, A. M. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00228.2004 · Cited by 141
Hubbard, B., Doege, H., Punreddy, S., Wu, H., Huang, X., Kaushik, V. K., Mozell, R. L., Byrnes, J. J., Stricker–Krongrad, A., Chou, C. J., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.012 · Cited by 136
Caligiuri, A., Bertolani, C., Guerra, C. T., Aleffi, S., Galastri, S., Trappoliere, M., Vizzutti, F., Gelmini, S., Laffi, G., Pinzani, M., et al. (2008) · Hepatology · doi:10.1002/hep.21995 · Cited by 136
Rooyen, D. M. V., Gan, L. T., Yeh, M. M., Haigh, W. G., Larter, C. Z., Ioannou, G. N., Teoh, N., & Farrell, G. C. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.024 · Cited by 132
Oakley, F., Teoh, V. W. Y., Ching-A-Sue, G., Bataller, R. A., Colmenero, J., Jonsson, J. R., Eliopoulos, A. G., Watson, M. R., Manas, D., & Mann, D. A. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.081 · Cited by 130
Self-citationMorán‐Salvador, E., Titos, E., Rius, B., González‐Périz, A., García‐Alonso, V., López‐Vicario, C., Miquel, R., Barak, Y., Arroyo, V., & Clària, J. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.06.023 · Cited by 123
Wei, Y., Wang, D., & Pagliassotti, M. J. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9461-2 · Cited by 123
Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression
Farrell, G. C., Larter, C. Z., Hou, J. Y., Zhang, R. H., Yeh, M. M., Williams, J., Dela Peňa, A., Francisco, R., Osvath, S. R., Brooling, J., et al. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05785.x · Cited by 120
Bechmann, L. P., Gieseler, R. K., Sowa, J.-P., Kahraman, A., Erhard, J., Wedemeyer, I., Emons, B., Jochum, C., Feldkamp, T., Gerken, G., et al. (2009) · Liver International · doi:10.1111/j.1478-3231.2010.02248.x · Cited by 120
The role of Hedgehog signaling in fibrogenic liver repair
Choi, S. S., Omenetti, A., Syn, W.-K., & Diehl, A. M. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.10.015 · Cited by 118
Leptin-specific mechanisms for impaired liver regeneration in ob/ob mice after toxic injury
Leclercq, I. A., Field, J., & Farrell, G. C. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00270-1 · Cited by 115
Petrasek, J., Dolganiuc, A., Csak, T., Kurt–Jones, E. A., & Szabo, G. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.08.020 · Cited by 112
Minervini, M. I., Ruppert, K. M., Fontes, P., Volpes, R., Vizzini, G. B., de Vera, M. E., Gruttadauria, S., Miraglia, R., Pipitone, L., Marsh, J. W., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.10.030 · Cited by 106
Preoperative donor liver biopsy for adult living donor liver transplantation: Risks and benefits
Nadalin, S., Malagó, M., Valentín-Gamazo, C., Testa, G., Baba, H. A., Liu, C., Frühauf, N. R., Schaffer, R. L., Gerken, G., Frilling, A., et al. (2005) · Liver Transplantation · doi:10.1002/lt.20462 · Cited by 106
Comparative Gene Expression Profiles Induced by PPARγ and PPARα/γ Agonists in Human Hepatocytes
Rogue, A., Lambert, C., Jossé, R., Antherieu, S., Spire, C., Claude, N., & Guillouzo, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018816 · Cited by 105
HCC Development Is Associated to Peripheral Insulin Resistance in a Mouse Model of NASH
De Minicis, S., Agostinelli, L., Rychlicki, C., Sorice, G. P., Saccomanno, S., Candelaresi, C., Giaccari, A., Trozzi, L., Pierantonelli, I., Mingarelli, E., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097136 · Cited by 97 · cited 1×
“Also, mice fed a CDAA diet develop peripheral IR after 1 month of treatment, and a progressive increase in body weight (102).”
BackgroundJha, P., Claudel, T., Baghdasaryan, A., Mueller, M., Halilbasic, E., Das, S. K., Lass, A., Zimmermann, R., Zechner, R., Hoefler, G., et al. (2014) · Hepatology · doi:10.1002/hep.26732 · Cited by 96
Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury?
Evans, C. D. J., Oien, K. A., MacSween, R. N. M., & Mills, P. R. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.9.689 · Cited by 95
Denda, A., Kitayama, W., Kishida, H., Murata, N., Tsutsumi, M., Tsujiuchi, T., Nakae, D., & Konishi, Y. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb01250.x · Cited by 93
Computer assisted quantitation of terminal hepatic vein connective tissue in the rat
Keegan, A. D., & Batey, R. G. (1992) · Pathology · doi:10.3109/00313029209068881 · Cited by 90
McClain, C. J., Barve, S., & Deaciuc, I. (2007) · Hepatology · doi:10.1002/hep.21788 · Cited by 88
Perttilä, J., Huaman-Samanez, C., Caron, S., Tanhuanpää, K., Staels, B., Yki-Järvinen, H., & Olkkonen, V. M. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00125.2011 · Cited by 87
TRAN, T. T., CHANGSRI, C., SHACKLETON, C., POORDAD, F. F., NISSEN, N. N., COLQUHOUN, S., GELLER, S. A., VIERLING, J. M., & MARTIN, P. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.03968.x · Cited by 84
Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification
Dyson, J. K., McPherson, S., & Anstee, Q. M. (2013) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2013-201620 · Cited by 78
Self-citationToll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis
Rivera, C. A., Gaskin, L., Allman, M., Pang, J., Brady, K., Adegboyega, P., & Pruitt, K. (2010) · BMC Gastroenterology · doi:10.1186/1471-230x-10-52 · Cited by 74
The Prevention by Choline of Liver Cirrhosis in Rats on High Fat, Low Protein Diets
Blumberg, H., & McCollum, E. V. (1941) · Science · doi:10.1126/science.93.2425.598 · Cited by 71
Genetic modifiers of non-alcoholic fatty liver disease progression
Anstee, Q. M., Daly, A. K., & Day, C. P. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.07.017 · Cited by 70
Self-citationA common variant in the adiponutrin gene influences liver enzyme values
Kollerits, B., Coassin, S., Kiechl, S., Hunt, S. C., Paulweber, B., Willeit, J., Brandstätter, A., Lamina, C., Adams, T. D., & Kronenberg, F. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2009.066597 · Cited by 70
Valenti, L., Alisi, A., & Nobili, V. (2012) · Hepatology · doi:10.1002/hep.25617 · Cited by 67
Lipid‐sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome
Vacca, M., Degirolamo, C., Mariani‐Costantini, R., Palasciano, G., & Moschetta, A. (2011) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.137 · Cited by 63
Clinical and pathological progression of non‐alcoholic steatohepatitis to hepatocellular carcinoma
Yasui, K., Hashimoto, E., Tokushige, K., Koike, K., Shima, T., Kanbara, Y., Saibara, T., Uto, H., Takami, S., Kawanaka, M., et al. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2012.00986.x · Cited by 60
Feitosa, M. F., Wojczynski, M. K., North, K. E., Zhang, Q., Province, M. A., Carr, J. J., & Borecki, I. B. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.01.038 · Cited by 58
Jiang, J. X., Mikami, K., Shah, V. H., & Torok, N. J. (2008) · Hepatology · doi:10.1002/hep.22515 · Cited by 54
The metabolic syndrome: how it may influence hepatic stellate cell activation and hepatic fibrosis
Lanthier, N., Horsmans, Y., & Leclercq, I. A. (2009) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32832c7819 · Cited by 47
Berk, P. D. (2008) · Hepatology · doi:10.1002/hep.22632 · Cited by 45
Wagner, M., Zollner, G., & Trauner, M. (2008) · Hepatology · doi:10.1002/hep.22668 · Cited by 40 · cited 9×
“LPS is delivered directly to the liver via the portal vein and is recognized by TLR4 located on Kupffer cells, the resident hepatic macrophages; activation of TLR4 by LPS requires coreceptors CD14 and MD-2 and results in activation of myeloid differentiation factor 88 (MyD88)– dependent and Toll/interleukin-1 receptor…”
BackgroundInfluentialLeptin and liver tissue repair: Do rodent models provide the answers?
Marra, F. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.10.002 · Cited by 40
Zietz, B., Lock, G., Straub, R. H., Braun, B., Schölmerich, J., & Palitzsch, K. D. (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1200 · Cited by 38
Plasma Adiponectin Decrease in Women with Nonalcoholic Fatty Liver
Matsubara, M. (2004) · Endocrine Journal · doi:10.1507/endocrj.51.587 · Cited by 34
Mechanisms of Simple Hepatic Steatosis
Matherly, S. C., & Puri, P. (2012) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.05.005 · Cited by 28
Failing FXR expression in the liver links aging to hepatic steatosis
Lefèbvre, P., & Staels, B. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.01.001 · Cited by 21
Francque, S., Maeght, S. D., Adler, M., Deltenre, P., de Galocsy, C., Orlent, H., Steenbergen, W. V., Bastens, B., Wain, E., Langlet, P., et al. (2011) · PubMed · Cited by 19
Comparative gene expression profiles induced by PPARγ and PPARα/γ agonists in rat hepatocytes
Rogue, A., Renaud, M. P., Claude, N., Guillouzo, A., & Spire, C. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.04.005 · Cited by 19
The importance of fatty liver disease in clinical practice
Cobbold, J., Anstee, Q. M., & Taylor-Robinson, S. D. (2010) · Proceedings of The Nutrition Society · doi:10.1017/s0029665110001916 · Cited by 18
Self-citation
Cited by
Rinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S., Abdelmalek, M. F., Caldwell, S., Barb, D., Kleiner, D. E., & Loomba, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000323 · Cited by 2,667
From NASH to HCC: current concepts and future challenges
Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O., & Heikenwalder, M. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0145-7 · Cited by 1,392
Self-citationThe intestinal barrier: a fundamental role in health and disease
Vancamelbeke, M., & Vermeire, S. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1343143 · Cited by 1,287
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
Diehl, A. M., & Day, C. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1503519 · Cited by 1,283
Self-citationSenescence and aging: Causes, consequences, and therapeutic avenues
McHugh, D., & Gil, J. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201708092 · Cited by 1,233
“The risk of developing nonalcoholic fatty liver disease increases with age (Hardy et al., 2016) and is predicted by the presence of senescent hepatocytes (Pellicoro et al.”
Background
Metadata
- Authors
- Hardy, T., Oakley, F., Anstee, Q. M., & Day, C. P.
- Venue
- Annual Review of Pathology: Mechanisms of Disease
- Publisher
- Annual Reviews
- Published
- 2016-05-23
- Volume
- 11
- Issue
- 1
- Pages
- 451-496
- ISSN
- 1553-4006 (ISSN-L)
- 1553-4014
- OpenAlex
- W2291173445
- Cited by
- 611
- References
- 306
- FWCI
- 8.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.